Therapeutic issues with pharmacological management Flashcards
Plasma level monitoring
Reasons for monitoring: establish therapeutic levels, evidence for toxicity, doubt about compliance, in cases where patient unable to report adverse effects (children, severe LD, dementia) and in overdose.
Monitoring for: lithium, carbamazepine, valproate, clozapine
Weight gain with psychiatric drugs
Worse with clozapine, chlorpromazine, olanzepine, quetiapine. Lower with risperidone and aripiprazole.
Lithium, mirtazepine, carbamazepine, valproate, gabapentin
Diabetes with antipsychotics
Common with SGAs
Need to determine baseline measures of glucose.
Treat with metformin or glucose
Hyperprolactinaemia with antipsychotics
Frequent with risperidone and amisulpride. Features include gynaecomastia, galactorrhoea and erectile dysfunction
Sexual dysfunction with psychiatric medication
Most likely with these ADs: clomipramine, SSRIs, venlafaxine
Most likely with these: FGAs and risperidone
Mood stabilisers - carbamazepine and phenytoin
Priapism
Trazodone is most likely due to alpha blockade
Anti-psychotic induced parkison
D2 receptor blockade
Clozapine/quetiapine least likely to effect movement
Use procyclidine anticholinergic
Akathisia
More risk in chronic, high dose, IM, rapid increase/sudden withdrawal, organic brain disease
Try chlorpromazine or quetiapine or clozapine
Beta-blockers and low-dose mirtazepine are anti-akathisias
Tardive dyskinesia
More common in elderly, organic brain disease
Clozapine best alternative
Dystonic reactions
Procyclidine in emergency management, IM and then continue for 5-7 days
Neuroleptic malignant syndrome
Rare, idiosyncratic
Fever, muscle rigidity, hyporeflexia, altered mental status, autonomic dysfunction (labile blood pressure, sweating, tachycardia)
Insidious onset over 2 weeks
Antipsychotics, antidepressents, mood stabiliers, antiemetics, methylphenidate
High mortality
Serotonin syndrome
A rare, but potentially fatal syndrome
Increase/initiate serotonergic agent
Symptoms: altered mental state, agitation, tremor, shivering, diarrhoea, hyperreflexia, myoclonus, ataxia, and hyperthermia.
Caused by: SSRIs, amfetamines, MAOIs, TCAs, lithium
Low mortality
Reversed with cryptoheptadine
Antidepressant discontinuation syndrome
SSRIs - paraesthesia, visual disturbance, shock-like sensation, dizziness, flu-like symptoms, GI symptoms, low mood, irritable, anxious, vivid dreams
Worse with paroxetine - short half-life and venlafaxine
Usually after 1 month treatment and 2-5 days after stopping
Hyponatraemia and antidepressants
Probably due to SIADH
Highest risk with citalopram, escitalopram, fluoxetine and sertraline
Lithium toxicity
Coarse tremor, vomiting, diarrhoea, slurred speech, ataxia, confusion